Amivantamab Compared with Real-World Physician's Choice after Platinum-Based Therapy from a Pan-European Chart Review of Patients with Lung Cancer and Activating <i>EGFR</i> Exon 20 Insertion Mutations. This evidence concerns the gene EGFR and lung cancer.